April 11, 2023 12:30 PM EDTUpdated 12:54 PM
Pharma
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie, Hori­zon, Mer­ck make cut for 100 best US work­places; Lil­ly taps new chief brand of­fi­cer

Beth Snyder Bulik

Senior Editor

The an­nu­al For­tune list of 100 best com­pa­nies to work for 2023 came out last week and in­clud­ed a hand­ful of phar­mas. Hori­zon Ther­a­peu­tics was …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times